Continuous variable modeling such as the Hodgkin lymphoma international prognostic index (A-HIPI) improves prognostic ...

Investigational obesity medicine maridebart cafraglutide (Amgen) showed clinically meaningful and dose-dependent weight loss among adults with obesity, with or without type 2 diabetes (T2D), according ...

A recent clinical trial found that a new TROP2-targeted antibody-drug conjugate (ADC) showed encouraging efficacy in treating ...

Innovations such as nurse navigators, AI-assisted prior authorizations, and community education—including rural outreach—are ...

The upcoming American Society of Hematology (ASH) 2025 meeting is poised to spotlight several pivotal developments across ...

Patients with polycythemia vera (PV) taking the investigational therapy rusfertide were able to largely maintain hematocrit control and avoid the need for phlebotomy over 52 weeks, according to ...

Quality improvement programs markedly increase sleep apnea testing in stroke patients, showing effective ways to improve guideline-based care.

Adding lumateperone (Caplyta; Johnson & Johnson) to ongoing antidepressant therapy (ADT) significantly improved depression severity in adults with major depressive disorder (MDD) who had not responded ...

The decision to use newer agents in relapsed/refractory follicular lymphoma is heavily influenced by the disease’s inherent ...

Antonio Urbina, MD, the medical director for the Mount Sinai Institute for Advanced Medicine 7th Avenue clinic in New York ...

Panelists discuss how PCSK9 inhibitors remain underused due to access, cost, and adherence barriers.

Minimally invasive treatment and earlier surgical consideration for thymectomy led the way as potential treatments for ...